1. High-Throughput Screening Core Facility at CU-Boulder Wei Wang 06-01-2015

2. HTS Core Facility Mission and Services Our mission is to promote chemical biology research and drug discovery at CU-Boulder and surrounding areas. We offer assistance on all steps involved in typical drug-discovery processes: 1. Assay development and validation 2. High-throughput screening 3. Data analysis, validation and lead identification 4. Structure and activity relationship (SAR) studies and large-scale production 5. In silico screen (we offer access to Schrodinger Suite )Schrodinger Suite and post-screen cheminformatic analysis

3. Compound Libraries and Instrumentation -FDA-approved drug library: 1,200 compounds (Prestwick Chemical) -Kinase- or protease-targeted library: 2,100 compounds (Biofocus) -Drug-like diversity library: 14,400 compounds (Maybridge HitFinder v11) -Drug-like diversity library: 10,000 compounds (ChemBridge) -Drug-like diversity library: 10,000 compounds (TimTec)

4. ScreenLibraryAssayTestPilotHTSHits Optimization RunScreen Validation Screen for inhibitors of PinK1-Parkin Kinase- & pathway (Liu Lab) protease-targeted Screen for agonists of Toll-like receptors (Yin Lab)Maybridge Screen for molecules that selectively potentiate the activity of β-lactamIndole alkaloids antibiotics in MRSA (Wang Lab) Screen for agonists of TLR5Maybridge (Yin Lab) Screen for antagonists of TLR5Maybridge (Yin Lab) Screen for agonists of TLR3Maybridge (Yin Lab) Screen for antagonists of TLR8Maybridge (Yin Lab) Summary of Recent Screens (I)

5. ScreenLibraryAssayTestPilotHTSHits Optimization RunScreen Validation Screen for JHDM1-class-selectiveMaybridge inhibitors (Facility and Wang Lab) Screen for agonists of TLR2 (Yin Lab) Maybridge Screen for antagonist of TLR2Maybridge (Yin Lab) Screen for antagonists of TLR7Maybridge (Yin Lab) Screen for compounds that disrupt replication of salmonella inside host Maybridge macrophages (Detweiler Lab) Screen for compounds that block MED1Maybridge and Tra interaction (Taatjies Lab) Screen for offshoots of type1 IFN signaling pathway that is responsible for suppressing response to IFNg FDA-approved drug library (Lenz Lab) Summary of Recent Screens (II)

6. YearAwardLabInstitute 2013Golfers Against Cancer Award Taatjes and Wang Dept. of Chem & Biochem 2014Bioscience Discovery Evaluation Grant Johnson Institute of Behavioral Genetics 2015Innovative Seed Grant DetweilerMCDB 2012-7NIH R21/R33 LenzDept. of Immunology and Microbiology, CU Anschutz Awarded Grants and Funding Opportunities NIH high throughput screening funding opportunities: Development of Assays for High-Throughput Screening for Use in Probe and Pre- therapeutic Discovery (R01) (PAR-13-364)(PAR-13-364) High Throughput Screening (HTS) to Discover Chemical Probes (R21) (PAR-14-283)(PAR-14-283) High Throughput Screening (HTS) to Discover Chemical Probes (R01) (PAR-14-284) (PAR-14-284)

7. Contact Us UCB215 Department of Chemistry and Biochemistry University of Colorado-Boulder Boulder, CO 80303 Wei Wang Manager E-mail: wang.wei@colorado.edu Office: 303 492 8740 Xiang Wang Director E-mail: xiang.wang@colorado.edu Office: 303 492 6266